X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.310
+0.170 (4.11%)
At close: May 29, 2026, 4:00 PM EDT
4.400
+0.090 (2.09%)
After-hours: May 29, 2026, 5:22 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $406.52 million as of May 29, 2026. Its market cap has increased by 2,021.64% in one year.
Market Cap
406.52M
Enterprise Value
250.05M
1-Year Change
2,021.64%
Ranking
Category
Stock Price
$4.31
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has increased from $101.77M to $406.52M, an increase of 299.44%. That is a compound annual growth rate of 21.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 390.48M | 11.65% |
| Dec 31, 2025 | 349.75M | 179.54% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 391.66M |
| Enanta Pharmaceuticals | 388.20M |
| Replimune Group | 387.27M |
| Vanda Pharmaceuticals | 386.37M |
| InflaRx | 381.49M |
| OmniAb | 375.48M |
| Artiva Biotherapeutics | 374.37M |
| Puma Biotechnology | 372.58M |